Nutra Pharma Corp. Reaches Settlement with SEC
- ByInvesting.com
- •
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Its Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Its Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain in horses. Its Luxury Feet is an over-the-counter pain reliever and anti-inflammatory product, which is designed for women who experience pain or discomfort due to high heels and stilettos. It also manufactures a zeolite detoxifier, Cell Defender for a third-party distributor.